New pill shows promise for rare blood disorder in Long-Term trial
Disease control
Not yet recruiting
This study looks at the long-term safety and effectiveness of NTQ5082 capsules for people with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease. About 78 adults who have already benefited from NTQ5082 or are on standard treatment will take the drug for up to severa…
Phase: PHASE3 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Disease control
Last updated May 11, 2026 20:47 UTC